Dr. Reddy�s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab

1 year ago

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis…

Introducing THE BRIJ – A World of Arts and Culture

1 year ago

Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple…

Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney

1 year ago

MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When…

Dongying seeks trade opportunities in overseas markets

1 year ago

DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China�s Shandong province, has been helping local enterprises expand in international markets as…

A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia

1 year ago

SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for more than two years, according…

Luxury beauty advisory SWISS REJU wins COSMOPOLITAN Best of the Best Panel�s Choice Award, celebrating exceptional body contouring results

1 year ago

HONG KONG SAR - Media Outreach - 19 December 2022 - Luxury beauty advisory SWISS REJU has been honored with…

Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies

1 year ago

HONG KONG SAR - Media OutReach - 19 December 2022 - A research team led by Hong Kong Baptist University…

LOFTER Group assisted with “Gingko House”, the social enterprise, to hold a series of activities to bring warmth to the community this winter

1 year ago

HONG KONG SAR - Media OutReach - 19 December 2022 - LOFTER GROUP ("LOFTER" or "the Group"), a Hong Kong-based…

ENHERTU� Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer

1 year ago

Daiichi Sankyo and AstraZeneca�s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in…

ENHERTU� Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer

1 year ago

First HER2 directed medicine to be approved for gastric cancer in the EU in more than a decade Based on…